Full-Time

Analyst II/Senior Analyst

Quality Control, Environmental Monitoring

Updated on 5/15/2024

Vor Bio

Vor Bio

51-200 employees

Develops cell therapies for blood cancers

Biotechnology

Senior

Cambridge, MA, USA

Required Skills
Communications
Requirements
  • BSc, MSc, PhD or equivalent life sciences degree
  • Minimum of 8 years pharmaceutical industry experience including 2+ years in Quality Control EM/Micro related role(s)
  • Experience with cell and gene therapy products preferred
  • Knowledge of cGMP and ICH requirements for pharmaceutical development and manufacturing, including technical knowledge of standard compendial and microbiological methods
  • Experience in regulatory inspections, including dealing with compliance issues identified by regulatory authorities preferred
  • Self-motivated individual who can handle multiple priorities to meet project team goals and timelines
  • Excellent written and verbal communication skills
Responsibilities
  • Execute overall environmental monitoring programs and related microbiology testing to support the internal manufacturing facility
  • Lead microbiology related testing for Vor's EM program and product support
  • Execute day-to-day EM/Micro operations to support manufacturing in GMP facilities
  • Ensure adherence to cGMP practices for QC Microbiology laboratory operations and testing
  • Support/lead continuous improvement initiatives related to EM topics
  • Lead investigations for EM excursions, microbial investigations, and out-of-specification results
  • Ensure current training for assigned responsibilities
  • Work safely within designated spaces and respond to safety inspections and audits as required/requested

Vor Bio, specializing in Hematopoietic Stem Cell (HSC) biology, genome engineering, and CAR-T cells, offers a technologically advanced approach to transforming the treatment of blood cancers like AML. By engineering cells to be resistant to targeted therapies, this company provides a promising career environment for those interested in contributing to groundbreaking advancements and working in a field that leads with cutting-edge cancer treatment solutions. Moreover, the focus on protecting healthy cells while eliminating cancerous ones post-transplant showcases a commitment to innovative and responsible research practices.

Company Stage

IPO

Total Funding

$267.8M

Headquarters

Cambridge, Massachusetts

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

14%

2 year growth

33%